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espiratory Instability
n Patients With
hronic Heart Failure*
laf Oldenburg, MD,
ieter Horstkotte, MD, PHD
ad Oeynhausen, Germany
bout 50% of patients with chronic heart failure suffer from
leep disordered breathing (1). The prevalence of obstructive
leep apnea (OSA) and central sleep apnea with Cheyne-
tokes respiration (CSR) differs in terms of chronic heart
ailure severity, with increasing prevalence of CSR with more
dvanced heart failure (1–4). Whereas OSA seems to be a risk
actor for the manifestation and deterioration of heart failure
er se (5,6), CSR is likely to mirror cardiac function and may
urther deteriorate cardiac function and prognosis (3,4,7,8).
See page 1832
In the past 25 years, research efforts were made to
nderstand pathophysiology, cardiovascular consequences,
nd therapeutic options of both types of sleep disordered
reathing. Although the impact of OSA on cardiovascular
iseases (9) and the indications for treatment by continuous
ositive airway pressure ventilation is widely accepted and
ecommended by current guidelines (10), the pathophysiol-
gy of CSR is not fully understood, and guidelines yet do
ot address therapeutic consequences.
Whereas OSA is caused by repetitive occlusion of the
pper airway (11), central sleep apnea with CSR is caused
y intermittent cessation of inspiratory drive due to a fall in
artial pressure of CO2 (pCO2) below the (altered) apnea
hreshold (12,13). However, CSR with the typical waxing and
aning ventilation pattern followed by central apnea represents
nly 1 expression of respiratory instability seen in advanced
eart failure. Other manifestations are increased VE/VCO2
lope and/or oscillatory breathing pattern during cardiopulmo-
ary exercise (14–16) or at rest (17).
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From the Department of Cardiology, Heart and Diabetes Centre North Rhinea
estphalia, Ruhr University Bochum, Bad Oeynhausen, Germany. The authors have
eported that they have no relationships to disclose.All these conditions can be characterized by inappropriate
hyper)ventilation with low arterial pCO2, increased sensi-
ivity of central and peripheral receptors to CO2, and an
ltered apnea threshold or a narrowed end-tidal pCO2
etween spontaneous breathing and apnea threshold, re-
pectively (13,16,18,19).
In this issue of the Journal, Giannoni et al. (20) present a
mall proof-of-concept study supporting the following the-
ry: Dynamic CO2 administration resulted in markedly
mproved oscillations in end-tidal CO2 and ventilation. By
dministration of CO2 during the peak of ventilation,
eriodic breathing (oscillation of ventilation) was reduced
uring voluntary periodic breathing in healthy subjects as
ell as in heart failure patients with spontaneous periodic
reathing. In parallel, mean oxygen saturation was increased
nd magnitude of desaturation reduced. In previous studies,
O2 administration was performed with a constant (static)
ow, not annoying the phase of ventilation (waxing, hyper-
entilation, waning, hypopnea, or apnea). However, even
ith this continuous flow of CO2, oscillatory ventilation
as reduced, supporting the concept of pCO2 dependency
f periodic breathing. In contrast to the present study,
revious studies using static CO2 administration were asso-
iated with an increase in end-tidal CO2, ventilation, and
ympathetic activity. The latter was not directly and reliably
easured in the present study, but no effects of dynamic
O2 administration on heart rate, blood pressure, or ven-
ricular ectopy were documented. Further studies are war-
anted to investigate the effects of dynamic CO2 adminis-
ration on ventilation, sleep, and sympathetic activity in
eart failure patients with nocturnal CSR.
Whereas the first studies using adaptive servoventilation
o treat nocturnal CSR in heart failure patients revealed
ood response regarding compliance (21), sleep parameters
22), and cardiac function (23–26), its impact on long-term
utcome is still unknown and part of ongoing clinical
utcome trials. In addition, the algorithms of some available
daptive servoventilation devices are designed to decrease
atient’s spontaneous minute ventilation and increase
CO2, which may result in improved respiratory stability.
Giannoni et al. (20) suggest dynamic CO2 administration
s an alternative to positive airway pressure ventilation
herapy applied via nasal or full-face masks. However, in
his case, CO2 administration needs to be performed using
asal cannula and ventilation needs to be reliably measured
ithout using a pneumotachograph—a method not tested
o far.
We congratulate Giannoni et al. (20) for their proof-of-
oncept study pointing out the crucial role of CO2 in the
athophysiology of respiratory instability seen in heart
ailure patients. We encourage them to set up a pilot study,
nvestigating not only the ventilatory effects of dynamic
O2 administration, but also the effects on sympatheticctivation, sleep, and heart failure parameters.
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